3,3',4,5'-tetrahydroxystilbene and Cardiomyopathies, Primary

3,3',4,5'-tetrahydroxystilbene has been researched along with Cardiomyopathies, Primary in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Chen, G; Chen, H; Fan, H; Gao, L; Huang, G; Liu, B; Tan, Z; Wu, Y; Xie, L; Xu, H; Zhou, C; Zhou, Y	1

Other Studies

1 other study(ies) available for 3,3',4,5'-tetrahydroxystilbene and Cardiomyopathies, Primary

Article	Year
Piceatannol protects against sepsis-induced myocardial dysfunction via direct inhibition of JAK2. International immunopharmacology, 2021, Volume: 96 Topics: Animals; Apoptosis; Cardiomyopathies; Cardiotonic Agents; Cell Line; Disease Models, Animal; Inflammation; Janus Kinase 2; Male; Mice, Inbred C57BL; Molecular Docking Simulation; Molecular Dynamics Simulation; Myocytes, Cardiac; Rats; Sepsis; Signal Transduction; STAT3 Transcription Factor; Stilbenes; Tyrphostins	2021

Article

Year

Piceatannol protects against sepsis-induced myocardial dysfunction via direct inhibition of JAK2.

International immunopharmacology, 2021, Volume: 96

Topics: Animals; Apoptosis; Cardiomyopathies; Cardiotonic Agents; Cell Line; Disease Models, Animal; Inflammation; Janus Kinase 2; Male; Mice, Inbred C57BL; Molecular Docking Simulation; Molecular Dynamics Simulation; Myocytes, Cardiac; Rats; Sepsis; Signal Transduction; STAT3 Transcription Factor; Stilbenes; Tyrphostins

2021